January/February 2016

Feature

Perspectives

The Role of Patient Navigation in Improving the Value of Oncology Care

02/16/2016

Sheryl Riley, RN, OCN, CMCN

Cortney Riley, BS, DPT

Abstract: Today, cancer patients face many challenges when trying to understand and navigate the health care system. These challenges begin at the time of diagnosis and continue throughout treatment, follow-up care,...

...

02/16/2016

Journal of Clinical Pathways

From the Field

Facilitating Physician Adherence to Clinical Pathways Across a Multi-Site Oncology Practice Network

02/16/2016

Brian J Gebhardt, MD

Sushil Beriwal, MD

Dwight E Heron, MD, MBA, FACRO, FACR

Abstract: With so many new developments in the field on oncology, physicians have a difficult time staying abreast of new guidelines and recommendations for different disease states. Clinical pathways are an...

...

02/16/2016

Journal of Clinical Pathways

Column

Clinical Pathways GPS

The Role of Patient Adherence in Successful Clinical Pathway Implementation

02/16/2016

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Scott Guerin, PhD

When considering the development of clinical pathways, the pathway itself is only the beginning; optimum outcomes cannot be realized unless patients follow their prescribed treatments. Simply having prescribers write...

When...

02/16/2016

Journal of Clinical Pathways

Insights

Interview

Why a Patient-Centered Approach to Clinical Pathways Must Include Palliative Care

02/16/2016

An interview with Geoffrey P Dunn, MD, General Surgeon, UPMC-Hamot, Pittsburgh, PA With the development of ever improving treatments for cancers of all types, the relative 5-year survival rate for all cancers has...

An...

02/16/2016

Journal of Clinical Pathways

Interview

National Committee for Quality Assurance and the Value of the Patient-Centered Medical Home

02/16/2016

JCP Editors

An interview with Margaret E O’Kane, President, and Manasi A Tirodkar, PhD, MS, Research Scientist, National Committee for Quality Assurance Years of rising health care costs and variability in the quality of care...

An...

02/16/2016

Journal of Clinical Pathways

News

Conference Coverage

2015 American Society of Hematology Annual Meeting & Exposition

02/16/2016

JCP Editors

In April of 1958, the American Society of Hematology (ASH) was formed in Atlantic City, NJ, when 300 hematologists gathered to share their insights regarding blood diseases. Today, ASH is one of the world’s largest...

In...

02/16/2016

Journal of Clinical Pathways

Department

Research in Review

Health Information Exchange Reduces Unnecessary Imaging, Lowers Costs

02/16/2016

JCP Editors

Access to an electronic health information exchange (HIE) system can reduce costs associated with unnecessary repeated imaging tests, claims a new study.  Imaging procedures such as x-rays or ultrasounds...

Access...

02/16/2016

Journal of Clinical Pathways

Research in Review

Treatment Pattern Mining to Account for Comorbidities During Clinical Pathway Execution

02/16/2016

JCP Editors

A study conducted by a group of Chinese researchers has shown that incorporating latent treatment pattern mining during clinical pathway execution can help clinicians better account for comorbidities likely to...

...

02/16/2016

Journal of Clinical Pathways

Research in Review

Electronic Clinical Pathways Program Improves Care for Several Disease States

02/16/2016

JCP Editors

Using an electronic system to guide clinical pathway usage can have substantial efficiency benefits over paper-based systems, a new study finds.  Several studies have found that clinical pathways, when...

Using...

02/16/2016

Journal of Clinical Pathways

Research in Review

Critical Success Factors for Clinical Pathway Implementation Identified

02/16/2016

JCP Editors

Despite research supporting the usefulness of clinical pathways for reducing the variability of care in clinical practice, a large percentage of clinical pathway initiatives have been unsuccessful. In a new report,...

...

02/16/2016

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

January/February 2016

Feature

Column

Insights

News

Department

Current Issue

Special Reports

Subscribe

December 2016 Volume 2

Specialties

Events

Year Round Education

HMP Global Products